Podcasts about personal genomics

In this episode, Dr. Whitfield speaks with Ashley Koff, RD, about the fascinating world of peptide hormones, focusing on GLP-1 and its role in metabolic health. Dr. Whitfield starts by highlighting how our genes play a part and why GLP-1 is so crucial, especially when bouncing back after surgery. Ashley, a whiz on GLP-1 agonists, chats about the differences between synthetic and natural hormones. She also stresses the importance of seeing metabolic health as a complex system. Ashley shares how personal genomics can help us fine-tune our health and gives us a sneak peek into her upcoming book on optimizing GLP-1. Tune in to hear more about a holistic and personalized approach to health and nutrition. Connect with Ashley Koff, RD https://thebetternutritionprogram.com/bnp-plan/ https://thebetternutritionprogram.com/join-our-newsletter/ Show Highlights: Genetic Factors in Metabolic Health (00:04:28) Impact of genetics on metabolic function and health outcomes GLP-1's Role in Repair (00:15:33) GLP-1's potential in repairing the digestive tract lining and considerations for its use Understanding Medication Use (00:16:25) Prevalence of acid-suppressing medications and their effects on digestion and inflammation GLP-1 Optimization Insights (00:22:25) Significance of GLP-1 hormones in regulating health and addressing weight management Importance of Nutrition Ecosystem (00:26:28) Discussion on the interconnectedness of diet, gut health, and overall body function Fermented Foods and Their Benefits (00:30:36) Exploration of various fermented foods and their role in enhancing gut health and nutrition Nutritional Yeast Misconceptions (00:33:16) Clarification on the nutritional content of fortified nutritional yeast and its impact on health Fermented Foods and Probiotics (00:34:12) Exploration of the limitations of fermented foods like sourdough for probiotic intake Protein Quality and Distribution (00:40:02) Importance of protein source quality and proper distribution throughout the day Genetic Factors in Nutrition (00:45:49) Discussion on the role of genetics in individual dietary needs and behaviors Bio: Ashley Koff, RD Ashley Koff, RD, leads the national conversation on truly personalized nutrition. She's translated her 25+ years of practitioner experience into a proven system, 'BNP' (better not perfect), to help you identify and make better nutrition choices more often. She's the founder of The Better Nutrition Program and the founding Nutrition Director for the University of California at Irvine's Susan Samueli Institute's Integrative and Functional Medicine Fellowship. Koff has a new book available in January 2026 on GLP-1 optimization from Harper Collins and offers certification for it for coaches and practitioners. She's also the author of two consumer publications, Recipes for IBS and Mom Energy, and a contributor to three practitioner publications. She was also the on-air dietitian for three reality TV shows and a regular contributing expert for national and local media outlets. Awarded by InStyle magazine as Hollywood's Leading Nutritionist, as among CNN's Top 100 health makers, recognized in the Top 10 Social Health Makers in Nutrition (Sharecare.com) and among the top “50 Natural Influencers” in health and nutrition to follow on Twitter (NewHope360 and Shape.com), Koff was also selected for the first list of Top 10 Registered Dietitians in the US by Today's Dietitian. Links and Resources Let's Connect Podcast: https://podcasts.apple.com/gb/podcast/breast-implant-illness/id1678143554 Spotify: https://open.spotify.com/show/1SPDripbluZKYsC0rwrBdb?si=23ea2cd9f6734667 TikTok: https://www.tiktok.com/@drrobertwhitfield?t=8oQyjO25X5i&r=1 IG: https://www.instagram.com/breastimplantillnessexpert/ FB: https://www.facebook.com/DrRobertWhitfield Linkedin: https://www.linkedin.com/in/dr-robert-whitfield-md-50775b10/ X: https://x.com/rob_whitfieldmd Read this article - https://www.breastcancer.org/treatment/surgery/breast-reconstruction/types/implant-reconstruction/illness/breast-implant-illness Shop: https://drrobssolutions.com SHARP: https://www.harp.health NVISN Labs - https://nvisnlabs.com/ Get access to Dr. Rob's Favorite Products below: Danger Coffee - Use our link for mold free coffee - https://dangercoffee.com/pages/mold-free-coffee?ref=ztvhyjg JASPR Air Purifier - Use code DRROB for the Jaspr Air Purifier - https://jaspr.co/ Echo Water - Get high quality water with our code DRROB10 - https://echowater.com/ BallancerPro - Use code DRROBVIP for the world's leader in lymphatic drainage technology - https://ballancerpro.com Ultrahuman - Use code WHITFIELD10 for the most accurate wearable - https://www.ultrahuman.com/ring/buy/us/?affiliateCode=drwhitfield

Pacific Biosciences of California, Inc. v. Personal Genomics Taiwan, I

In our data-heavy age, data becomes a treasure, a currency, a valuable good. This is true especially for the biotech and pharmaceutical industries, where data can inform the development of novel drugs. But should own biomedical data – and where should the lines between privacy and patient benefit be drawn? In the new episode of We're doomed, we're saved, Andreas Horchler and Louise von Stechow discuss new strategies of data sharing and ownership in biomedicine and pharma.

Anne Wojcicki is an innovative biologist and the co-founder and CEO of personal genomics company 23andMe.In 2006, Anne saw a need for creating a way to generate more personalized information so that commercial and academic researchers could better understand and develop new drugs and diagnostics. The result was 23andMe, which provides genetic testing for individuals curious about their ancestry and genetic makeup.It was named "Invention of the Year" by Time Magazine in 2008, and in 2013, The Fast Company named Anne “The Most Daring CEO.”We spoke with Anne all about her upbringing and the story of how 23andMe came to be.*The Founder Hour is brought to you by Outer. Outer makes the world's most beautiful, comfortable, innovative, and high-quality outdoor furniture - ALL from sustainable materials - and is the ONLY outdoor furniture with a patented built-in cover to make protecting it effortless. From teak chairs to fire pit tables, everything Outer makes has the look and feel of what you'd expect at a 5-star resort, for less than you'd pay at a big box store for something that won't last.For a limited time, get 10% off and FREE shipping at www.liveouter.com/thefounderhour. Terms and conditions apply.*This episode is brought to you by “More Than Profit.” If you enjoy The Founder Hour, we think you'll enjoy this podcast too. It celebrates entrepreneurs, investors, and leaders that are living and working with purpose. The host, Bryce Butler, sits down with his guests and shares personal stories about what it's like to succeed…and even fail. But more than that, what motivates them beyond just profit to press forward in their work and as a leader.Check out “More Than Profit” wherever you get your podcasts or at www.morethanprofit.fm.

Nick talks to genetics researcher & writer Razib Khan. Razib did graduate work in genetics at the University of California-Davis and recently founded a genomics data startup. He also runs a Substack, "Unsupervised Learning," where he writes a lot of fascinating articles on the subjects of human evolutionary & population genetics, personal genomics, and more. Nick and Razib discussed: how the story of human evolution has changed over the past two decades; genomics technology & ancient DNA; Neanderthals, Denisovans & ancient humans; personal genomics (e.g. 23AndMe, Ancestry.com); Razib's experience as a writer on Substack.SUPPORT M&M:Sign up for the free weekly Mind & Matter newsletter:[https://mindandmatter.substack.com/?sort=top]Learn how you can further support the podcast: [https://mindandmatter.substack.com/p/how-to-support-mind-and-matter]Learn more about our podcast sponsor, Dosist[https://dosist.com]ABOUT Nick Jikomes:Nick is a neuroscientist and podcast host. He is currently Director of Science & Innovation at Leafly, a technology startup in the legal cannabis industry. He received a Ph.D. in Neuroscience from Harvard University and a B.S. in Genetics from the University of Wisconsin-Madison.Support the show

This is a turn of the decade (and January-themed) look backward/ look forward into personal genomics, given recent and past retrospective and prospective pieces in the media on the promise, and perils, of the ability to sequence one's DNA: What did it, and does it, mean for personalized medicine, criminal investigations, privacy, and more?General partner Jorge Conde, who has a long history in the space, covers everything from where genealogy databases and large datasets come in to fetal testing, multi-omics, and other themes spanning the past, present, and future of personal genomics in conversation with Sonal Chokshi for episode #18 our news show 16 Minutes, where we cover recent headlines, the a16z way, from our vantage point in tech -- and especially what's hype/ what's real. While we typically cover multiple headlines, this is one of our special deep-dive episodes on a single topic. (You catch up on other such deep dives, on the opioid crisis and other evergreen episodes, at a16z.com/16Minutes). And if you haven't already, be sure to subscribe to the separate feed for "16 Minutes" to continue getting new episodes. image: Petra Fritz / Flickr

For our first episode of 2020 -- #18 of our show 16 Minutes, where we cover recent headlines, the a16z way, from our vantage point in tech, and especially what's hype/ what's real -- we do one of our special deep-dive episodes on a single topic: personal genomics.It’s a turn of the decade — and January-appropriate! — look backward/ look forward given recent and past retrospective and prospective pieces in the media on the promise, and perils, of the ability to sequence one’s DNA and what it means for personalized medicine, criminal investigations, privacy, and so on.Our a16z expert for this episode is general partner Jorge Conde, who has a long history in the space, in conversation with host Sonal Chokshi. They cover everything from where genealogy databases and large datasets come in to fetal testing, multi-omics, and much more spanning past, present, and future.

Welcome to Personal Genomics, a podcast from the Center for Cancer Genomics at the National Cancer Institute. In upcoming episodes, you’ll hear personal stories from researchers about what really motivates them to work in one of the most complex areas of cancer research. Listen to our trailer to get a taste of what’s to come.

Razib Khan is a geneticist, blogger, and man about the internet. Razib is the kind of extremely online intellectual we like here at Other Life. Razib has written for publications including The New York Times, India Today, National Review Online, Slate, and The Guardian. Razib and I talked about the present and near-future of personal genomics; why Razib thinks Elizabeth Warren's genetic claims are reasonable (though Razib is a conservative); is 23andme worth it?; how sperm banks work; why skilled immigrants don't want to stay in the US anymore; why Razib doesn't like science videos on Youtube, etc. We also discussed academia vs. the internet, and different monetization models for intellectual work. This conversation was first recorded as a livestream on Youtube. You can subscribe to my channel with one click, then click the bell to receive notifications when future livestreams begin. As always, big thanks to all my patrons — I really could not keep all this running without you.

In this episode of Health Stories, Erik is talking to Othman Laraki (@othman) and Alicia Zhou (@ay_zhou) of Color. Othman is co-founder and CEO and Alicia Zhou is Head of Research. Othman explains the personal reason that he started Color and why he got involved in the healthcare space after previously working at Google and running a company that was acquired by Twitter.Alicia and Othman explain the advances Color has made in genomics and how the approach they’re taking is different from that of other companies in the space. You might not have known that 30% of your health is related to your genome. There are also a number of new types of care that can be unlocked by having your genome sequenced.Othman explains how at Color they are hoping to follow the model of Google or Amazon where early in the company’s life they focus on doing one thing really well, then expand into other areas. He also talks about where he would be building a company in the space if he wasn't working at Color as well as where he might look to invest. They also discuss the time Othman wore a glucose monitor full-time and how it changed how he thinks about health, why he is hoping for an “iPhone moment” in the healthcare space, and why the future of cancer treatment will be much more about prevention than treatment.Thanks for listening — if you like what you hear, please review us on your favorite podcast platform. Check us out on the web at villageglobal.vc or get in touch with us on Twitter @villageglobal.Venture Stories is brought to you by Village Global and is hosted by co-founder and partner, Erik Torenberg. Colin Campbell is our audio engineer and the show is produced by Brett Bolkowy.

In this episode of Health Stories, Erik is talking to Othman Laraki (@othman) and Alicia Zhou (@ay_zhou) of Color. Othman is co-founder and CEO and Alicia Zhou is Head of Research. Othman explains the personal reason that he started Color and why he got involved in the healthcare space after previously working at Google and running a company that was acquired by Twitter.Alicia and Othman explain the advances Color has made in genomics and how the approach they’re taking is different from that of other companies in the space. You might not have known that 30% of your health is related to your genome. There are also a number of new types of care that can be unlocked by having your genome sequenced.Othman explains how at Color they are hoping to follow the model of Google or Amazon where early in the company’s life they focus on doing one thing really well, then expand into other areas. He also talks about where he would be building a company in the space if he wasn't working at Color as well as where he might look to invest. They also discuss the time Othman wore a glucose monitor full-time and how it changed how he thinks about health, why he is hoping for an “iPhone moment” in the healthcare space, and why the future of cancer treatment will be much more about prevention than treatment.Thanks for listening — if you like what you hear, please review us on your favorite podcast platform. Check us out on the web at villageglobal.vc or get in touch with us on Twitter @villageglobal.Venture Stories is brought to you by Village Global and is hosted by co-founder and partner, Erik Torenberg. Colin Campbell is our audio engineer and the show is produced by Brett Bolkowy.

eGPLearning Podblast Personal Genomics Special Shownotes In this episode, Andy describes his experience of using the 23andme's personal genetics service. We discuss his impressions, both positive and not so positive as well as privacy concerns and what the future might hold for personal genetics and how General Practice might be involved. We also explore the use of the BNF clinical app.eGPlearning Podblast is a health tech talk by two Nottingham based GPs covering recent topics, useful clinical apps, and interviews with primary care health tech innovators.Hosted by Dr Hussain Gandhi (@drGandalf52) and Dr Andrew Foster (@drawfoster). Shout outs:@sonaliKinra, @ncgpaNottm, @nottsLMC Gandhi update (1.50)Fasting in Ramadan is not easyPodcasting for innovait - the @rcgp AiT journal - check out the latest episode shortly with @doctormayur and @dr_zoThank you to all the #eGPlearners for helping with rebranding of @egplearning  Andy update (3.00)On @nottstv talking about GP plus extended GP services in Nottingham. App review: BNF Smartphone App (4.00)https://www.bnf.org/products/bnfbnfcapp/HANDI (Handbook of Non-drug interventions) website (10.00)A useful collection of non-drug resources for clinicians and patients.  Down to our Personal Genomics (10.30) Definition: “Personal genomics or consumer genetics is the branch of genomics concerned with the sequencing, analysis and interpretation of the genome of an individual” Who are 23andMe?US based startup founded 2006.Direct to consumer personal genome testingCEO Anne Wojcicki used to be married to google's Sergy Brin, google an early investorSpit in a tube and they will analyse your genetic material, mitochondiral and chromosomal and present the resultsThey give you the opportunity to:See an ancestory reportFind genetic relations (who want to be found)See a report about inherited traits - baldness, unibrow….Be aware of genetics risks for serious health problems The process?Order the kit - £79 Ancestory, £149 full serviceRegister accountSpit in a tube and post backWait 2-3 weeksHumanOmniExpress-24 format chip - partial SNP (single nucleotide polymorphisms) looks at parts of the genome known to vary between individuals.Get an email saying results are readyLook at results.Can seeSee an ancestry reportFind genetic relations (who want to be found)See a report about inherited traits - baldness, unibrow….Carrier status

This week we talk about citizen science, genealogy services, and serial killers.We also discuss genetic privacy, HR 1313, and DNA analysis. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit letsknowthings.substack.com/subscribe

This week we talk about citizen science, genealogy services, and serial killers. We also discuss genetic privacy, HR 1313, and DNA analysis. For more information about this podcast and to view the copious show notes, visit letsknowthings.com. Become a patron on Patreon: patreon.com/letsknowthings You can find a list of the books I've written at Colin.io. I'm going on tour: BecomingTour.com

In this bonus episode, Graycen and Alison talk about how the alleged Golden State Killer was caught and some of the thorny issues around personal genomics.

PANELISTS: JASON BOBE Jason Bobe is Associate Professor and Director of the Sharing Lab at Icahn Institute at Mount Sinai. For the past 10 years, Jason has been at the forefront of innovative data sharing practices in health research. His work on the Personal Genome Project at Harvard, and now three other countries, pioneered new approaches for creating well-consented public data, cell lines and other open resources. These efforts led to important changes in the governance of identifiable health data and also led to the development of valuable new products, such as NIST's standardized human genome reference materials (e.g. NIST RM 8392), now used for calibrating clinical laboratory equipment worldwide. More recently, he co-founded Open Humans, a platform that facilitates participant-centered data sharing between individuals and the health research community. At the Sharing Lab, he attempts to produce health research studies that people actually want to join and works on improving our understanding of how to make great, impactful studies capable of engaging the general public and achieving social good. He is alsothe leader of the Resilience Project, an effort leveraging open science approaches to identify and learn how some people are able avoid disease despite having serious risk factors. Last year, he was selected to be in the inaugural class of Mozilla Open Science Fellows. He is also co-founder of two nonprofits: Open Humans Foundation and DIYbio.org. SOPHIE ZAAIJER Dr. Sophie Zaaijer is a Postdoctoral Researcher in the Erlich's lab at the New York Genome Center and Columbia University. Sophie is from the Netherlands, where she did her undergraduate in Music (viola) and Food Technology. For her Masters, she studied Medical Biotechnology at Wageningen University and went to Harvard Medical School to finish her thesis work in Monica Colaiacovo's lab. She next went on to do a PhD in Molecular Biology and Genetics in Julie Cooper's lab at Cancer Research UK, London (now the Crick Institute) and at the National Institutes of Health, Bethesda. Sophie focuses on genome technology and the growing impact of genomics on our daily lives. MODERATOR: HEATHER DEWEY-HAGBORG Heather Dewey-Hagborg is a transdisciplinary artist and educator who is interested in art as research and critical practice. Her controversial biopolitical art practice includes Stranger Visions in which she created portrait sculptures from analyses of genetic material (hair, cigarette butts, chewed up gum) collected in public places. Heather has shown work internationally at events and venues including the World Economic Forum, Shenzhen Urbanism and Architecture Biennale, the New Museum, and PS1 MOMA. Her work has been widely discussed in the media, from the New York Times and the BBC to TED and Wired. She is an Assistant Professor of Art and Technology Studies at the School of the Art Institute of Chicago and a 2016 Creative Capital award grantee in the area of Emerging Fields. INTRODUCTION: DANIEL GRUSHKIN Daniel Grushkin is founder of the Biodesign Challenge, an international university competition that asks students to envision future applications of biotech. He is co-founder and Cultural Programs Director of Genspace, a nonprofit community laboratory dedicated to promoting citizen science and access to biotechnology. Fast Company ranked Genspace fourth among the top 10 most innovative education companies in the world. Daniel is a Fellow at Data & Society. From 2013-2014, he was a fellow at the Woodrow Wilson International Center for Scholars where he researched synthetic biology. He was an Emerging Leader in Biosecurity at the UPMC Center of Health Security in 2014. As a journalist, he has reported on the intersection of biotechnology, culture, and business for publications including Bloomberg Businessweek, Fast Company, Scientific American and Popular Science.

The Balfour Chair of Genetics was established at Cambridge in 1912. As part of its centenary celebrations the Department of Genetics has produced a short film following the development of the subject in the University over the past 100 years. In the early 20th century the establishment of genetic research in Britain was driven primarily by William Bateson. As Steward of St John's College and later Professor of Biology in the University,  Bateson played a key role in demonstrating the applicability of Mendel's laws to a variety of organisms, particularly animals. As well as laying the foundations for a renewed interest in the study of heredity, it was Bateson who coined the term Genetics. In 1912, largely as a result of Bateson's championing of the subject, the University established the Balfour Professorship of Genetics that in time would lead to the formation of the modern Department of Genetics. The first incumbent of the Chair was Reginald Punnett, known to students of biology throughout the world for his eponymous square. In the hundred years since this event Genetics has passed from being an eccentric mixture of mathematics, gardening and biology to become the core of the biological sciences. Our film tells the story of the role of Cambridge and the Department of Genetics in this journey.

Duke University geneticist Misha Angrists genome is a public document, thanks to his participation in Harvard's Personal Genome Project. Angrist reflects on the medical and ethical implications of the project in his 2010 book, Here is a Human Being: At the Dawn of Personal Genomics.

Duke University geneticist Misha Angrists genome is a public document, thanks to his participation in Harvard's Personal Genome Project. Angrist reflects on the medical and ethical implications of the project in his 2010 book, Here is a Human Being: At the Dawn of Personal Genomics.

Misha Angrist, PhD Assistant Professor of the Practice Duke University Institute for Genome Sciences & Policy Here is a Human Being: At the Dawn of Personal Genomics Misha Angrist knows the field of personal genomics well. In April 2007, he became the fourth subject in Harvard geneticist George Church's Personal Genome Project. In 2009, he was among the first few people to have his entire genome sequenced. Dr. Angrist will share his experience as chronicled in is book, Here is a Human Being: At the Dawn of Personal Genomics, and present the pros, cons, and potential impact of personal genomics on human health and society. Misha Angrist holds a PhD degree in Genetics from Case Western Reserve University, and was formerly a board-eligible genetic counselor. He received his MFA in Writing and Literature from the Bennington Writing Seminars, is a past winner of the Brenda L. Smart Fiction Prize, and was nominated for the Pushcart Prize. Dr. Angrist was born and raised in Pittsburgh, PA. Don't miss this month's installment of Café Sci! Tim Palucka, Angela Stabryla and Linda Ortenzo, co-organizers Café Scientifique Pittsburgh Monday, June 6, 2011 at 7 pm Carnegie Science Center